Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4-10.
暂无分享,去创建一个
[1] Graham M Lord,et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. , 2002, The Journal of clinical investigation.
[2] M. Iida,et al. Central α-melanocyte-stimulating hormone acts at melanocortin-4 receptor to activate sympathetic nervous system in conscious rabbits , 2002, Brain Research.
[3] M. Tota,et al. The role of melanocortins in body weight regulation: opportunities for the treatment of obesity. , 2002, European journal of pharmacology.
[4] S. Bhattacharyya,et al. A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism. , 2002, Human molecular genetics.
[5] Christopher P Austin,et al. A role for the melanocortin 4 receptor in sexual function , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[6] G. Barsh,et al. Genetic approaches to studying energy balance: perception and integration , 2002, Nature Reviews Genetics.
[7] Jan Born,et al. Sniffing neuropeptides: a transnasal approach to the human brain , 2002, Nature Neuroscience.
[8] J. Bolognia,et al. The melanocortin-1 receptor: red hair and beyond. , 2001, Archives of dermatology.
[9] R. Cone,et al. Knockout models resulting in the development of obesity. , 2001, Trends in genetics : TIG.
[10] J. Drouin,et al. A Pituitary Cell-Restricted T Box Factor, Tpit, Activates POMC Transcription in Cooperation with Pitx Homeoproteins , 2001, Cell.
[11] J. Born,et al. The melanocortin melanocyte-stimulating hormone/adrenocorticotropin(4-10) decreases body fat in humans. , 2001, The Journal of clinical endocrinology and metabolism.
[12] V. Hruby,et al. Effect of an alpha-melanocyte stimulating hormone analog on penile erection and sexual desire in men with organic erectile dysfunction. , 2000, Urology.
[13] S. Bloom,et al. The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptin. , 2000, The Journal of clinical investigation.
[14] A. Grüters,et al. Implications of Proopiomelanocortin (POMC) Mutations in Humans: The POMC Deficiency Syndrome , 2000, Trends in Endocrinology & Metabolism.
[15] R. Cone. Haploinsufficiency of the melanocortin-4 receptor: part of a thrifty genotype? , 2000, The Journal of clinical investigation.
[16] T. Luger,et al. The Role of α‐MSH as a Modulator of Cutaneous Inflammation , 2000 .
[17] N. Seidah,et al. The Subtilisin/Kexin Family of Precursor Convertases: Emphasis on PC1, PC2/7B2, POMC and the Novel Enzyme SKI‐1 , 1999, Annals of the New York Academy of Sciences.
[18] A. Prentice,et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. , 1999, The New England journal of medicine.
[19] L. Yaswen,et al. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin , 1999, Nature Medicine.
[20] S. Takahashi,et al. Molecular cloning and characterization of the chicken pro-opiomelanocortin (POMC) gene. , 1999, Biochimica et biophysica acta.
[21] J. Wikberg,et al. Melanocortin receptors: perspectives for novel drugs. , 1999, European journal of pharmacology.
[22] O. Pedersen,et al. Mutational analysis of the proopiomelanocortin gene in Caucasians with early onset obesity , 1999, International Journal of Obesity.
[23] A. Clark,et al. Adrenocorticotropin insensitivity syndromes. , 1998, Endocrine reviews.
[24] J. Hebebrand,et al. Systematic mutation screening of the pro-opiomelanocortin gene: identification of several genetic variants including three different insertions, one nonsense and two missense point mutations in probands of different weight extremes. , 1998, The Journal of clinical endocrinology and metabolism.
[25] A. Grüters,et al. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans , 1998, Nature Genetics.
[26] R. Cone,et al. Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in Mice , 1997, Cell.
[27] Victor J. Hruby,et al. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome , 1997, Nature.
[28] H. Steiner,et al. Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin , 1996, Nature.
[29] B. Zemel,et al. Resting energy expenditure in clinical pediatrics: measured versus prediction equations. , 1995, The Journal of pediatrics.
[30] C. Cowell,et al. Cholestatic jaundice and congenital hypopituitarism , 1995, Journal of paediatrics and child health.
[31] R. Cone,et al. Differential effects of melanocortin peptides on neural melanocortin receptors. , 1994, Molecular pharmacology.
[32] S. Watson,et al. Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. , 1993, The Journal of biological chemistry.
[33] A. Lerner. The Discovery of the Melanotropins: A History of Pituitary Endocrinology a , 1993, Annals of the New York Academy of Sciences.
[34] S. Watson,et al. Molecular cloning of a novel melanocortin receptor. , 1993, The Journal of biological chemistry.
[35] M. Mortrud,et al. The cloning of a family of genes that encode the melanocortin receptors. , 1992, Science.
[36] M. Kozak. The scanning model for translation: an update , 1989, The Journal of cell biology.
[37] B. Weintraub,et al. Decreased receptor binding of biologically inactive thyrotropin in central hypothyroidism. Effect of treatment with thyrotropin-releasing hormone. , 1985, New England Journal of Medicine.
[38] T. Miyata,et al. Complete nucleotide sequence of the human corticotropin-beta-lipotropin precursor gene. , 1983, Nucleic acids research.
[39] J. Jolles,et al. Neuropeptides derived from pro-opiocortin: behavioral, physiological, and neurochemical effects. , 1982, Physiological reviews.
[40] S. Nakanishi,et al. Isolation and structural organization of the human corticotropin‐β‐lipotropin precursor gene , 1981, FEBS letters.
[41] W. Rutter,et al. The proopiocortin (adrenocorticotropin/β-lipotropin) gene is located on chromosome 2 in humans , 1981 .
[42] T. W. Greidanus,et al. Relationships between α-MSH levels in blood and in cerebrospinal fluid , 1980, Brain Research Bulletin.
[43] N. Seidah,et al. From β-lipotropin to β-endorphin and 'pro-opio-melanocortin' , 1979 .
[44] J. B. Weir. New methods for calculating metabolic rate with special reference to protein metabolism , 1949, The Journal of physiology.
[45] Mohamad Maghniea,et al. The Pituitary , 1919, The Indian Medical Gazette.
[46] J. Flier,et al. Transcriptional regulation of the thyrotropin-releasing hormone gene by leptin and melanocortin signaling. , 2001, The Journal of clinical investigation.
[47] L. Perrone,et al. Molecular screening of the proopiomelanocortin (POMC ) gene in Italian obese children: report of three new mutations , 2001, International Journal of Obesity.
[48] T. Luger,et al. The role of alpha-MSH as a modulator of cutaneous inflammation. , 2000, Annals of the New York Academy of Sciences.
[49] T J Cole,et al. Body Mass Index variations: centiles from birth to 87 years. , 1991, European journal of clinical nutrition.
[50] D. Jacobowitz,et al. Hypothalamic hypothyroidism caused by lesions in rat paraventricular nuclei alters the carbohydrate structure of secreted thyrotropin. , 1988, Endocrinology.
[51] P. Seeburg,et al. The human pro-opiomelanocortin gene: organization, sequence, and interspersion with repetitive DNA. , 1982, DNA.
[52] A. D. de Rotte,et al. Relationships between alpha-MSH levels in blood and in cerebrospinal fluid. , 1980, Brain research bulletin.
[53] G. Schubert. [On the accuracy of indirect calorimetry]. , 1960, Nutritio et dieta; European review of nutrition and dietetics.